Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

Human and Experimental Toxicology

Volumn 24, Issue 3, 2005, Pages 137-147

  Ahmad, Muzamil ^a   Saleem, Sofiyan ^a   Ahmad, Abdullah Shafique ^a   Ansari, Mubeen Ahmad ^a   Yousuf, Seema ^a   Hoda, Md Nasrul ^a   Islam, Fakhrul ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

6 hydroxydopamine; Antioxidant; Dopamine; Oxidative stress; Parkinson's disease; Withania somnifera

Indexed keywords

CATALASE; CATECHOLAMINE; DOPAMINE RECEPTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; OXIDOPAMINE; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE; WITHANIA SOMNIFERA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; WITHANIA SOMNIFERA;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; MALE; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PLANT EXTRACTS; RATS; RATS, WISTAR; WITHANIA;

PARKINSONIA; WITHANIA SOMNIFERA;

EID: 18044398197     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht509oa     Document Type: Article

References (45)

1. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): A review. Alternive Medicine Reviews 2000; 5: 334-46.
2. Davis L, Kuttan G. Effect of Withania somnifera on DMBA-induced carcinogenesis. Journal of Ethnopharmacology 2001; 75: 165-68.
3. Bhattacharya A, Ghosal S, Bhattacharya SK. Antioxidant effect of Withania somnifera glycowithanolides in chronic foot-shock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. Journal of Ethnopharmacology 2001; 74: 1-6.
4. Chaurasia SS, Panda S, Kar A. Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mouse. Pharmacological Research 2000; 41: 663-66.
5. Panda S, Kar A. Evidence for free radical scavenging activity of Ashwagandha root powder in mice. Indian Journal of Physiology Pharmacology 1997; 41: 424-26.
6. Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of ashwagandha and ginseng. Journal of Ethnopharmacology 1994; 44: 131-35.
7. Dhuley JN. Effect of Ashwagandha on lipid peroxidation in stress-induced animals. Journal of Ethnopharmacology 1998; 60: 173-78.
8. Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D et al. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 1995; 67: 631-47.
9. Perese DA, Ulman J, Viola J, Ewing SE, Bankiewicz KS. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Research 1989; 494: 285-93.
10. Sachs C, Jonsson G. Mechanisms of action of 6-hydroxydopamine. Biochemical Pharmacology 1975; 24: 1-8.
11. Perumal AS, Gopal VB, Tordzro WK, Cooper TB, Cadet JL. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Research Bulletin 1992; 29: 699-701.
12. Kumar R, Agarwal AK, Seth PK. Free radical-generated neurotoxicity of 6-hydroxydopamine. Journal of Neurochemistry 1995; 64: 1703-707.
13. Paxinos G, Watson C. The rat brain stereotaxic coordinates. Sydney: Academic Press, 1982.
14. Utley HC, Bernheim F and Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Archives of Biochemistry and Biophyics 1967; 118: 29-32.
15. Jollow DJ, Mitchell JR Zampagloine N, Gillete JR. Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzene-oxide as the hepatotoxic intermediate. Pharmacology 1974; 11: 151-69.
16. Habig WH, Pabst MJ, Jokoby WB. Glutathion-S-transferase: The first enzymetic step in mercapturic acid formation. Journal of Biological Chemistry 1974; 249: 7130-39.
17. Athar M, Mukhtar H, Bickers DR, Khan IU, Kalyanaraman B. Evidence for the metabolism of tumor promoter organic hydroperoxides into free radicals by human carcinoma skin keratinocytes: an ESR-spin trapping study. Carcinogenesis 1989; 10: 1499-503.
18. Carlberg I, Mannervik B. Glutathione reductase levels in rat brain. Journal of Biological Chemistry 1975; 250: 5475-80.
19. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: Possible implication in analgesic neuropathy. Cancer Research 1984; 44: 5086-91.
20. Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anals of Biochemistry 1971; 44: 276-87.
21. Caliborne A. Catalase activity. In Green Wald RA ed. CRC Handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press, 1985: 283-84.
22. DeVito MJ, Wagner GC. Methamphetamine induced neuronal damage: a possible role for free radicals. Neuropharmacology 1989; 28: 1145-50.
23. Zafar KS, Sayeed I, Siddiqui A, Ahmad M, Salim S, Islam F. Dose-dependent rotective effect of selenium in partial lesion model of Parkinson's disease: neurobehavioral and neurochemical evidences. Journal of Neurochemistry 2003; 84: 438-46.
24. Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. Journal of Chemical Neuroanatomy 2003; 26: 143-51.
25. Agrawal AK, Hussin R Raghubir R, Kumar A, Seth PK. Neurobehavioral, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and transplanted rats. International Journal of Developmental Neuroscience 1995; 13: 105-11.
26. Lowry OH, Rosenbrough NJ, Far AL, Randall RJ. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265-75.
27. Dean RT, Roberts CR, Jessup W. Fragmentation of extracellular and intracellular polypeptides by free radicals. In Khirallah E, Bond J, Bird JWC eds. Intracellular protein catabolism. New York: Liss AR, 1985: 341-50.
28. Cohen G. Oxyradical toxicity in catecholamine neurons. Neurotoxicology 1984; 5: 77-82.
29. Cadet JL, Katz M, Jackson-Lewis V, Fahn S. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats. Behavioral and biochemical evidence. Brain Research 1989; 476: 10-15.
30. Ahmad M, Salim S, Ahmad AS, Yousuf S, Ansari MA, Chaturvedi R et al. Ginkgo biloba affords dose-dependent protection against 6-OHDA induced Parkinsonism in rats: Neurobehavioral, neurochemical and immunohistochemical evidences. Journal of Neurochemistry 2005 (in press).
31. Bhattacharya SK, Satyan KS, Ghoshal S. Antioxidant activiy of glycowithanolides from Withania somnifera. Indian Journal of Experimental Biology 1997; 74: 1-6.
32. Halliwell B, Gutteridge JMC. Oxygen radicals and the nervous system. Trends in Neuroscience 1985; 8: 22-29.
33. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Laboratory Investigations 1982; 47: 412-26.
34. Fridovich I. Superoxide dismutases: an adaptation to a paramagnetic gas. Journal of Biological Chemistry 1975; 264: 19328-33.
35. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of National Academy of Sciences USA 1990; 87: 1620-24.
36. Meister A. Glutathione metabolism and its selective medication. Journal of Biological Chemistry 1988; 263: 17205-208.
37. Matuszak Z, Reszka K, Chignell CF. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radical Biology and Medicine 1997; 23: 367-72.
38. Reiter RJ. Oxidative processes and antioxidative defence mechanisms in ageing brain. FASEB Journal 1995; 9: 526-33.
39. Huang J, Philbert MA.Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Research 1996; 711: 184-92.
40. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolite (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochemical Journal 1997; 324: 5-8.
41. Wu WR, Zhu XZ. Involvement of monoamine oxidase inhibition in neuroproective and neurorestorative effects of Gingko biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sciences 1999; 65: 157-64.
42. Schwarting RK, Huston JP. Unilateral 6-hydroxydopamine lesion of meso-striatal dopamine neurons and their sequelae. Progresses in Neurobiology 1996; 49: 215-66.
43. Hudson JL, Horny CG, Stromberg I, Brock S, Claton J, Masserano J et al. Correlation of apomorphine and amphetamine induced turning with nigrastrital dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Research 1993; 626: 167-74.
44. Carman LS, Gage FH, Shults CW. Partial lesion of the subtantia nigra: relation between extent of lesion and rotation behavior. Brain Research 1991; 553: 275-83.
45. 1 receptor stimulation. Journal of Neuroscience 1990; 10: 2318-29.